One such example is the uPAR-binding AE105 peptide, that was traced with 64Cu and successfully tested in mice by microPET for its specificity to target uPAR-bearing U87 glioblastoma cells (Li et al., 2008). The gene discussed is PLAUR; the disease is glioblastoma.